Eleanore Seibert

Eleanore Seibert has extensive work experience in the pharmaceutical industry. Eleanore began their career in 2004 as a Postdoctoral Associate at Boehringer Ingelheim. Over the years, they steadily progressed through various roles, including Senior Scientist, Principal Scientist, and Senior Associate Director. In 2015, they became an Executive Director and later held the position of Vice President, Drug Metabolism & Pharmacokinetics. Eleanore worked at Boehringer Ingelheim until at least April 2019. In 2021, Seibert joined BioCT as a Board Member. Before joining Boehringer Ingelheim, they had a research fellowship at the Institute for Cancer Prevention from 2003 to 2004.

Eleanore Seibert obtained a B.S. in Forensic Science from John Jay College of Criminal Justice from 1993 to 1997. From 1997 to 2002, they pursued a Ph.D. in Biochemistry & Biophysics at the Icahn School of Medicine at Mount Sinai. In 2012, they also obtained a Lean Six Sigma Black Belt certification from Boehringer Ingelheim.